Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update

Diogo Costa Leandro de Oliveira1, Fernanda Boldrini Assunção1, Alair Agusto Sarmet Moreira Damas Dos Santos1

  • 1Universidade Federal Fluminense, Rio de Janeiro, RJ, Brazil.

Insights

Hypertrophic cardiomyopathy (HCM) diagnosis and prognosis are enhanced by cardiac magnetic resonance (CMR) and cardiac computed tomography (CCT). These imaging techniques aid in identifying subclinical cases and guiding patient management for this common genetic heart disease.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) is the most prevalent genetic cardiovascular disease.
  • HCM is a leading cause of sudden cardiac death in young individuals.
  • Early diagnosis and risk stratification are crucial for managing HCM.

Purpose of the Study:

  • To elucidate the diagnostic and prognostic roles of Cardiac Magnetic Resonance (CMR) and Cardiac Computed Tomography (CCT) in HCM.
  • To explore the application of CMR and CCT in screening for subclinical HCM phenotypes.
  • To describe how advanced imaging influences the management strategies for HCM patients.

Main Methods:

  • Review of current literature on CMR and CCT in HCM.
  • Analysis of diagnostic accuracy and prognostic value of imaging findings.
  • Discussion of imaging-guided therapeutic interventions.

Main Results:

  • CMR and CCT demonstrate high sensitivity and specificity for HCM diagnosis.
  • Imaging can identify subclinical disease and stratify risk.
  • Advanced image analysis facilitates personalized management approaches.

Conclusions:

  • CMR and CCT are indispensable tools for the comprehensive evaluation of HCM.
  • These noninvasive imaging modalities are key to improving patient outcomes.
  • Integrating imaging insights into clinical practice is vital for effective HCM management.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
640
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
502
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
492
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
393
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
746
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
824